Interactions between the sympathetic nervous system and the immune system

Brain, Behavior, and Immunity

Volumn 13, Issue 4, 1999, Pages 271-278

  Schorr, Ewa Chelmicka ^a   Arnason, Barry G W ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR; ADRENERGIC RECEPTOR BLOCKING AGENT; ADRENERGIC RECEPTOR STIMULATING AGENT; ISOPRENALINE; TERBUTALINE;

ADOPTIVE TRANSFER; ADRENERGIC SYSTEM; ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; AUTOIMMUNE DISEASE; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; MULTIPLE SCLEROSIS; MYASTHENIA GRAVIS; NONHUMAN; PRIORITY JOURNAL; PSYCHOPHYSIOLOGY; RECEPTOR DENSITY; REVIEW;

EID: 0009772825     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1006/brbi.1999.0549     Document Type: Article

References (34)

1. Agius M. A., Checinski M. E., Richman D. P., Chelmicka-Schorr E. Sympathectomy enhances the severity of experimental autoimmune myasthenia gravis (EAMG). J. Neuroimmunol. 16:1987;11-12.
2. Alito A. E., Carlomagno M. A., Cardinali D. P., Brown M. Effect of regional sympathetic denervation of local immune reactions. Fed. Proc. 44:1985;564.
3. Bellinger D. L., Lorton D., Felten S. Y., Felten D. L. Innervation of lymphoid organs and implications in development, aging, and autoimmunity. Int. J. Immunopharmacol. 14:1992;329-344.
4. Bellinger D. L., Felten S. Y., Lorton D., Felten D. L. Innervation of lymphoid organs and neurotransmitter-lymphocyte interactions. Keane R. W., Hickey W. F. Immunology of the nervous system. 1997;Oxford Univ. Press, New York.
5. Bourne H. R., Lichtenstein L. M., Melmon K. L., Henney C. S., Weinstein Y., Shearer G. M. Modulation of inflammation and immunity by cAMP. Science. 184:1974;19-28.
6. Chelmicka-Schorr E., Checinski M., Arnason B. G. W. Chemical sympathectomy augments the severity of experimental allergic encephalomyelitis. J. Neuroimmunol. 17:1988;347-350.
7. Chelmicka-Schorr E., Kwasniewski M. N., Thomas B. E., Arnason B. G. W. The β-adrenergic agonist isoproterenol suppresses experimental allergic encephalomyelitis in Lewis Rats. J. Neuroimmunol. 25:1989;203-207.
8. Chelmicka-Schorr E., Checinski M. E., Arnason B. G. W. Sympathetic nervous system and PC12 pheochromocytoma-derived factors suppress stimulation of lymphocytes. Brain, Behav. Immun. 4:1990;23-29.
9. Chelmicka-Schorr E., Kwasniewski M. N., Czlonkowska A. Sympathetic nervous system modulates macrophage function. Int. J. Immunopharmacol. 14:1992a;841-846.
10. Chelmicka-Schorr E., Kwasniewski M. N., Wollmann R. L. Sympathectomy augments adoptively transferred experimental allergic encephalomyelitis. J. Neuroimmunol. 37:1992b;99-103.
11. 2-adrenergic agonist terbutaline suppresses acute passive transfer experimental autoimmune myasthenia gravis (EAMG). Int. J. Immunopharmacol. 19:1993;24.
12. Felten D. L., Felten S. Y., Bellinger D. L. Noradrenergic sympathetic neural interactions with the immune system: Structure and function. Immunol. Rev. 100:1987;225.
13. Hall N. R., McClure J. E., Hu S. K. Effects of 6-hydroxy-dopamine upon primary and secondary thymus dependent immune responses. Immunopharmacology. 5:1982;39-48.
14. Kahn M. M., Sansoni P., Silverman E. D., Engleman E. G., Melmont K. L. Beta-adrenergic receptors on human suppressor, helper, and cytolytic lymphocytes. Biochem. Pharmacol. 35:1986;1137-1142.
15. Karaszewski J. W., Reder A. T., Maselli R., Brown M., Arnason B. G. W. Sympathetic skin responses are decreased and lymphocyte beta-adrenergic receptors are increased in progressive multiple sclerosis. Ann. Neurol. 27:1990;366-372.
16. Karaszewski J. W., Reder A. T., Anlar B., Kim W. C., Arnason B. G. W. Increased lymphocyte beta-adrenergic receptor density in progressive multiple sclerosis is specific for the CD8+, CD28-suppressor cell. Ann. Neurol. 30:1991;42-47.
17. Karaszewski J. W., Reder A. T., Anlar B., Arnason B. G. W. Increased high affinity beta-adrenergic receptor densities and cyclic AMP responses of CD8 cells in multiple sclerosis. J. Neuroimmunol. 43:1993;1-8.
18. Kasahara K., Tanaka S., Ite T., Hamashima Y. Suppression of the primary immune response by chemical sympathectomy. Res. Commun. Chem. Pathol. Pharmacol. 16:1977;687-694.
19. Kendall M. D., Al-Shawaf A. A. Innervation of the rat thymus gland. Brain, Behav. Immun. 5:1991;9-28.
20. 2-adrenergic agonist terbutaline suppresses experimental allergic neuritis in Lewis rats. J. Neuroimmunol. 51:1994;177-183.
21. Kruszewska B., Felten S. Y., Moynihan J. A. Alterations in cytokine and antibody production following chemical sympathectomy in two strains of Mice. J. Immunol. 155:1995;4613-4620.
22. Li Y. S., Kouassi E., Revillard J. P. Differential regulation of mouse B-cell activation by β-adrenoceptor stimulation depending on type of mitogens. Immunology. 69:1990;367-372.
23. Mackenzie F. J., Leonard J. P., Cuzner M. L. Changes in lymphocyte β-adrenergic receptor density and noradrenaline content of the spleen are early indicators of immune reactivity in acute experimental allergic encephalomyelitis in the Lewis rat. J. Neuroimmunol. 23:1989;93-100.
24. Madden K. S., Felten D. L. Experimental basis for neural-immune interactions. Physiol. Rev. 75:1995;77.
25. Maisel A. S., Fowler P., Rearden A., Motulsky H. J., Michel M. C. A new method for isolation of human lymphocyte subsets reveals differential regulation of β-adrenergic receptors by terbutaline treatment. Clin. Pharmacol. Ther. 46:1989;429-439.
26. Miles K., Chelmicka-Schorr E., Quintans J., Richman D. P., Otten G., Arnason B. G. W. Immune regulation by the sympathetic nervous system. Neurology. 31:1981a;137.
27. Miles K., Quintans J., Chelmicka-Schorr E., Arnason B. G. W. The sympathetic nervous system modulates antibody response to thymus-dependent antigens. J. Neuroimmunol. 1:1981b;101-106.
28. Miles K., Chelmicka-Schorr E., Atweh S., Otten G., Arnason B. G. W. Sympathetic ablation alters lymphocyte membrane properties. J. Immunol. 135:1985;797s-801s.
29. Reder A. T., Checinski M., Chelmicka-Schorr E. The effect of chemical sympathectomy on natural killer cells in mice. Brain, Behav. Immun. 3:1989;110-118.
30. Renold F. K., Checinski M. E., Magilavy D. B., Chelmicka-Schorr E. 6-Hydroxydopamine (60HDA) neonatal sympathectomy prolongs survival of MRL/lpr mice. Arthritis Rheum. 31:1988;s38.
31. Wiegmann K., Muthyala S., Kim D., Arnason B. G. W., Chelmicka-Schorr E. β-Adrenergic agonists suppress chronic/relapsing experimental allergic encephalomyelitis (CREAE) in Lewis Rats. J. Neuroimmunol. 56:1995;201-206.
32. Williams J. M., Peterson R. G., Shea P. A. Sympathetic innervation of murine thymus and spleen: Evidence for a functional link between the nervous and immune systems. Brain Res. Bull. 6:1981;83-94.
33. Zoukos Y., Leonard J. P., Thomaides T., Thompson A. J., Cuzner M. L. β-Adrenergic receptor density and function of peripheral blood mononuclear cells are increased in multiple sclerosis: A regulatory role for cortisol and interleukin-1. Ann. Neurol. 31:1992;657-662.
34. Zoukos Y., Kidd D., Woodroofe M. N., Kendall B. E., Thompson A. J., Cuzner M. L. Increased expression of high affinity IL-2 receptors and β-adrenoreceptors in peripheral blood mononuclear cells is associated with clinical and MRI activity in multiple sclerosis. Brain. 117:1994;307-315.